Literature DB >> 27020982

The Ontogeny and Microenvironmental Regulation of Tumor-Associated Macrophages.

Kiavash Movahedi1,2, Jo A Van Ginderachter1,2.   

Abstract

SIGNIFICANCE: Tumor progression is supported by non-cancerous stromal cells, of which tumor-associated macrophages (TAMs) are prominent constituents. These cells could be considered promising therapeutic targets, but this requires a better understanding of their heterogeneity under the influence of tumor microenvironmental cues and/or ontogenic differences. Recent Advances: The availability of oxygen is an important regulator of the TAM phenotype, as well as of its access to myelopoietic growth factors. Very recent evidence also demonstrated that macrophages can be derived from embryonal precursors or from monocytes post-birth, introducing yet another level of heterogeneity among macrophages. CRITICAL ISSUES: The relative contribution of ontogenically distinct macrophages to tumor characteristics is, to a large extent, still an open question. In addition, further knowledge on the role of tumor microenvirontal cues that shape TAMs is warranted. FUTURE DIRECTIONS: More detailed insights into the TAM-regulating factors will provide new opportunities for therapeutic intervention. Interference with the phenotypes of TAM, which are known to be immunosuppressive and to contribute to dysfunctional tumor blood vessels, is anticipated to be beneficial in combination with chemotherapy and/or immunotherapy. Antioxid. Redox Signal. 25, 775-791.

Entities:  

Keywords:  cancer; hypoxia; inflammation; macrophage; tumor microenvironment

Mesh:

Year:  2016        PMID: 27020982     DOI: 10.1089/ars.2016.6704

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  22 in total

1.  A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment.

Authors:  Cheng-Liang Kuo; Han-Yu Chou; Hui-Wen Lien; Chia-An Yeh; Jing-Rong Wang; Chung-Hsing Chen; Chi-Chen Fan; Chih-Ping Hsu; Ting-Yu Kao; Tai-Ming Ko; Alan Yueh-Luen Lee
Journal:  Cancer Immunol Immunother       Date:  2022-07-27       Impact factor: 6.630

Review 2.  Roles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer.

Authors:  Qi Liu; Wei Sun; Hao Zhang
Journal:  Front Pharmacol       Date:  2022-04-11       Impact factor: 5.988

Review 3.  Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy.

Authors:  Shweta Joshi; Andrew Sharabi
Journal:  Pharmacol Ther       Date:  2022-02-02       Impact factor: 13.400

Review 4.  Plasticity of myeloid-derived suppressor cells in cancer.

Authors:  Evgenii Tcyganov; Jerome Mastio; Eric Chen; Dmitry I Gabrilovich
Journal:  Curr Opin Immunol       Date:  2018-03-14       Impact factor: 7.486

Review 5.  Tumour-associated macrophages as treatment targets in oncology.

Authors:  Alberto Mantovani; Federica Marchesi; Alberto Malesci; Luigi Laghi; Paola Allavena
Journal:  Nat Rev Clin Oncol       Date:  2017-01-24       Impact factor: 66.675

Review 6.  Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma.

Authors:  H Degroote; A Van Dierendonck; A Geerts; H Van Vlierberghe; L Devisscher
Journal:  J Immunol Res       Date:  2018-10-16       Impact factor: 4.818

7.  Redox-responsive self-assembly PEG nanoparticle enhanced triptolide for efficient antitumor treatment.

Authors:  Yanchun Wang; Xuewei Liu; Xuemei Wang; Wei Zheng; Junping Zhang; Feng Shi; Junbao Liu
Journal:  Sci Rep       Date:  2018-08-28       Impact factor: 4.379

Review 8.  Biomechanical Contributions to Macrophage Activation in the Tumor Microenvironment.

Authors:  Erica J Hoffmann; Suzanne M Ponik
Journal:  Front Oncol       Date:  2020-05-20       Impact factor: 6.244

9.  Macrophages as prognostic biomarkers in human melanoma.

Authors:  Rafael Samaniego; Alba Gutiérrez-Seijo; Paloma Sánchez-Mateos
Journal:  Oncoscience       Date:  2018-06-30

Review 10.  Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer.

Authors:  Bilikis Aderonke Abolarinwa; Ridwan Babatunde Ibrahim; Yen-Hua Huang
Journal:  Int J Mol Sci       Date:  2019-09-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.